AstraZeneca announces FluMist Quadrivalent approved and available in Canada; Sinovac gets CFDA approval to start clinical trials of varicella vax;

> AstraZeneca ($AZN) Canada announced the approval and availability of FluMist Quadrivalent. Release

> Beijing-based Sinovac Dalian ($SVA) got approval from the China FDA to begin clinical trials of its varicella vaccine. Release

> Indian Immunologicals announced that its new $38 million facility to produce human and animal vaccines has begun operations. Story